Suppliers / Mylan Dublin

Mylan Dublin

India Updated 9 July 2026

Mylan Dublin is a finished-dose manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with US FDA, JFDA (JO) and MCAZ (ZW). Its GMP standing is certified by CDSCO (India) and MHRA (UK).

2
active US DMFs
0
valid CEPs
12
registered plants
558
filings across 4 regulators

Registered plants

Site FDA FEI
Bangalore- 562105, United Arab Emirates Not on file
Bangalore 562105, United Arab Emirates Not on file
DUBLIN, Ireland Not on file
BANGALORE, India Not on file
Hosur –, India Not on file
hosur 635 130, India Not on file

6 further sites are on record.

What they file, and where

Molecule Regulators Docs
Fomepizole US FDA 1
Isosulfan Blue US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 546 None
JFDA (JO) 9 None
MCAZ (ZW) 2 None
EDE (AE) 1 None
CDSCO (India) None 10
MHRA (UK) None 2

Comparing suppliers?

Choose your molecules and target markets. Mylan Dublin comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 79 active litigation matters are on record.
  • One recent serious compliance event is on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates